Aptevo Therapeutics Inc

NASDAQ:APVO   3:59:41 PM EDT
43.76
-0.63 (-1.42%)
Products, Regulatory

Alligator And Aptevo To Initiate Phase I Clinical Development

Published: 11/16/2020 13:12 GMT
Aptevo Therapeutics Inc (APVO) - Aptevo Therapeutics and Alligator Bioscience Advancing the Bispecific 4-1bbx5t4 Antibody Alg.
Apv-527 Into Phase I Clinical Development.companies Anticipate Filing a Clinical Trial Authorization During First Half of 2021 to Initiate Phase I Clinical Development in Multiple Sites in European Union.